SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ADC Therapeutics SA (ADCT) News

Follow ADC Therapeutics SA (ADCT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ADCT Asset equity Sector Markets 90 days 6 Last 1.29 Updated Nov 09, 2026, 01:13 PM UTC Open live news feed Open ADCT chart & news
M ADC Therapeutics Reports Q3 Revenue of $21 Million, Runway Into 2029 ADC Therapeutics reported Q3 2026 net product revenue of $21.0 million, up from $15.8 million a year earlier, and a net loss of $25.3 million. It ended September with $189.2 million in cash and cash equivalents. EQUITY | Nov 09, 2026, 01:13 PM UTC M ADC Therapeutics Q3 Revenue Beats Estimates on Sales Volume EQUITY | Nov 09, 2026, 12:42 PM UTC M ADC Therapeutics Reports Third-Quarter 2026 Results, Operational Updates ADC Therapeutics reported $21 million in third-quarter net product revenue and $189.2 million in cash and cash equivalents as of September 30, 2026. The company said a financial restructuring extends its expected cash ru EQUITY | Nov 09, 2026, 12:31 PM UTC M ADC Therapeutics reports third-quarter loss per share EQUITY | Nov 09, 2026, 12:30 PM UTC M ADC Therapeutics Raises $86.6 Million in Financing, Amends Loan and Royalty Deals ADC Therapeutics announced a $86.6 million private placement of common shares and pre-funded warrants, alongside amendments to its Blue Owl loan and HCR royalty agreements. The loan amendment follows a $70 million prepay EQUITY | Oct 13, 2026, 10:33 AM UTC L ADC Therapeutics to participate in 2026 Cantor Global Healthcare Conference ADCT says it will participate in the 2026 Cantor Global Healthcare Conference. EQUITY | Sep 03, 2026, 11:15 AM UTC L ADCT: ADC Therapeutics reports Q2 2026 results, operational updates ADC Therapeutics (ADCT) reports second-quarter 2026 financial results and provides operational updates, according to a TradeXchange Newsdesk notice. EARNINGS | Aug 13, 2026, 11:30 AM UTC L ADCT - ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 ADCT - ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 EARNINGS | Aug 06, 2026, 11:30 AM UTC